Ready to get certified?
Free CDCES Coach App
Subscribe
eNewsletter
Download
Free Med Pocket Cards
Simplifying Insulin Delivery with CeQur Simplicity
By: Sarah Beattie, DNP, APRN-CNP, CDCES The American Diabetes Association estimates that over 8 million people in the United States depend on insulin therapy for survival.¹ Multiple daily injections (MDI) … Continue reading Simplifying Insulin Delivery with CeQur Simplicity
Question of the Week | RT Forgot Their Insulin- Best Response?
RT has type two diabetes and has been maintaining a time and range of 70% or greater. However, when they show up at the office, the last week’s time in … Continue reading Question of the Week | RT Forgot Their Insulin- Best Response?
Rationale of the Week | FIB-4 of 2.83. What Action Required?
For last week’s practice question, we quizzed participants on FIB-4 of 2.83. 48.09% of respondents chose the best answer. We want to clarify and share this important information, so you … Continue reading Rationale of the Week | FIB-4 of 2.83. What Action Required?
Updates in Lifestyle Therapy for MASLD and MASH
By: Christine Craig, MS, RD, CDCES Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) and metabolic dysfunction-associated steatohepatitis (MASH) are now recognized as high-risk health conditions for people living with diabetes. Two … Continue reading Updates in Lifestyle Therapy for MASLD and MASH
Question of the Week | Diabetes Tech and Diabetes Distress
Kyle is a 55-year-old man with type 2 diabetes for ten years. He was recently diagnosed with retinopathy in both eyes. His grandmother lost her eyesight due to diabetes. Due … Continue reading Question of the Week | Diabetes Tech and Diabetes Distress
Rationale of the Week | Which Treatment is FDA Approved for MASH?
For last week’s practice question, we quizzed participants on FDA approved treatment for MASH. 33.75% of respondents chose the best answer. We want to clarify and share this important information, … Continue reading Rationale of the Week | Which Treatment is FDA Approved for MASH?
Question of the Week | FIB-4 of 2.83. What Action Required?
AR lives with type 2 diabetes, and their waistline is 41 inches. Since their ALT and AST levels are elevated, you know they are at risk for steatosis (MASH). You … Continue reading Question of the Week | FIB-4 of 2.83. What Action Required?
Rationale of the Week | Lifestyle Therapy for MASLD and MASH
For last week’s practice question, we quizzed participants on Lifestyle Therapy for MASLD and MASH. 83% of respondents chose the best answer. We want to clarify and share this important … Continue reading Rationale of the Week | Lifestyle Therapy for MASLD and MASH
